Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer
暂无分享,去创建一个
Xian Chen | K. Hunt | M. McArthur | K. Keyomarsi | S. Vijayaraghavan | Dong Yang | Yufeng Jiang | Tuyen N Bui | Natalie A Jabbour-Leung